CEL-SCI Corp. (CVM)
1.58
-0.03
(-1.86%)
USD |
NYAM |
Aug 27, 14:31
CEL-SCI Price to Book Value : 2.537 for Aug. 27, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 26, 2026 | 2.585 |
| August 25, 2026 | 2.376 |
| August 24, 2026 | 2.216 |
| August 21, 2026 | 2.280 |
| August 20, 2026 | 2.344 |
| August 19, 2026 | 2.633 |
| August 18, 2026 | 2.553 |
| August 17, 2026 | 2.488 |
| August 14, 2026 | 2.472 |
| August 13, 2026 | 2.392 |
| August 12, 2026 | 2.376 |
| August 11, 2026 | 2.440 |
| August 10, 2026 | 2.392 |
| August 07, 2026 | 2.761 |
| August 06, 2026 | 2.585 |
| August 05, 2026 | 2.440 |
| August 04, 2026 | 2.183 |
| August 03, 2026 | 2.007 |
| July 31, 2026 | 1.862 |
| July 30, 2026 | 1.959 |
| July 29, 2026 | 1.830 |
| July 28, 2026 | 1.926 |
| July 27, 2026 | 1.894 |
| July 24, 2026 | 1.894 |
| July 23, 2026 | 1.910 |
| Date | Value |
|---|---|
| July 22, 2026 | 1.975 |
| July 21, 2026 | 2.007 |
| July 20, 2026 | 2.039 |
| July 17, 2026 | 1.878 |
| July 16, 2026 | 1.846 |
| July 15, 2026 | 1.846 |
| July 14, 2026 | 1.846 |
| July 13, 2026 | 1.959 |
| July 10, 2026 | 2.216 |
| July 09, 2026 | 2.167 |
| July 08, 2026 | 2.264 |
| July 07, 2026 | 2.055 |
| July 06, 2026 | 2.039 |
| July 02, 2026 | 1.830 |
| July 01, 2026 | 1.686 |
| June 30, 2026 | 1.670 |
| June 29, 2026 | 1.334 |
| June 26, 2026 | 1.371 |
| June 25, 2026 | 1.204 |
| June 24, 2026 | 1.229 |
| June 23, 2026 | 1.260 |
| June 22, 2026 | 1.248 |
| June 18, 2026 | 1.285 |
| June 17, 2026 | 1.359 |
| June 16, 2026 | 1.248 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.26 |
| Anika Therapeutics, Inc. | 2.059 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.782 |
Price to Book Value Related Metrics
| Price | 1.58 |
| Earnings Yield | -163.5% |
| Market Cap | 27.79M |